SIGNUP FOR
NEWSLETTER
TSX: HSM
NASDAQ: HSDT
Call us: +1 877-564-0008
About
Back
Overview
Meet Our Team
Advisory Board
Scientific Interests
Divisions
Back
Overview
Helius Medical
Back
The PoNS Device
Investor Relations
Back
Overview
Stock Info
Events
Back
Upcoming Events
Past Events
Code of Conduct
Corporate Documents
Committee Charters
SEC Filings
Financial Information
Back
2019
Back
Q2 2019
Q1 2019
2018
Back
Q4 2018
Q3 2018
Q2 2018
Q1 2018
2017
Back
Q4 2017
Q3 2017
Q2 2017
Q1 2017
2016
Back
Q3 2016
Q2 2016
Q1 2016
2015
Back
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Investor FAQ
Newsroom
Back
News Releases
Back
2021
2020
2019
2018
Archive
Back
2017
2016
2015
2014
In the News
Back
HMT Coverage
Related Science
Media Resources
Our Research
Back
Overview
Clinical Trials
Peer-Reviewed Publications
Words to Know
Research Partners
Contact
Back
Contact HMT
Subscribe Newsletter
Careers
Back
Home
Newsroom
News Releases
Archive
Menu
News Releases
2021
2020
2019
2018
Archive
2017
2016
2015
2014
In the News
HMT Coverage
Related Science
Media Resources
Stock Quote - HSM-T
*Delayed quote courtesy of Google.
Stock Quote - HSDT
*Delayed quote courtesy of Google.
2016 News Releases
Filters
- Select Tag -
Clinical News
Corporate News
Filter
List of articles in category 2016 News Releases
Title
Date
Full Enrollment Reached in Tactile Communication and Neurorehabilitation Laboratory Clinical Trial
05 Dec, 2016
Helius Medical Technologies and HealthTech Connex Announce Preliminary Research Results Supporting Objective Physiologic Improvement in Cognitive Function with Investigational PoNS™ Therapy in Healthy Adults and Expand Combined Research Initiative
02 Dec, 2016
Helius Medical Technologies and U.S. Army Extend Sole Source Contract for the PoNS Device Testing and Development
21 Nov, 2016
Brain Injury Advocates Team Up to “Tackle TBI” in New Public Service Announcement
10 Nov, 2016
November 9, 2016 Helius Key Opinion Leader Conference Call Details
08 Nov, 2016
Helius Medical Technologies to Receive ISO 13485 Certificate – Precursor Certification for Regulatory Applications in Europe, Canada and Australia
27 Oct, 2016
Helius Medical Technologies Announces Publication of Positive Results of Russian Pediatric Cerebral Palsy Pilot Study
06 Sep, 2016
Helius Medical Technologies Opens New Site for Pivotal Mild to Moderate Traumatic Brain Injury Trial at HealthTech Connex in Surrey, British Columbia
31 Aug, 2016
Helius Medical Technologies Appoints Thomas Griffin to Board of Directors and Chairman of the Audit Committee.
08 Aug, 2016
Helius Medical Technologies Announces that Registration Statement on Form S-1 has been Declared Effective
13 Jul, 2016
Helius Medical Technologies to Present at 93rd Annual ACRM Conference Plenary Session
27 Jun, 2016
Helius Medical Technologies Announces Results from a Case Series of Subjects with Advanced MS
21 Jun, 2016
Helius Medical Technologies Rings the Opening Bell of the Toronto Stock Exchange
15 Jun, 2016
Helius Medical Announces Proceeds of $1.4 Million from Exercise of Warrants
06 Jun, 2016
Helius Medical Developing New Tech for Brain Trauma
26 May, 2016
Helius Medical Technologies Restates and Re-files Historical Financial Statements for Non-Cash Reclassification of Warrants
26 Apr, 2016
Helius Medical Technologies Restates and Re-files Historical Financial Statements
11 Jan, 2016
Helius Medical Technologies Announces Allowances of 10 New Patents
04 Jan, 2016